Contact Supplier

Contact Supplier

To get in touch with Biosynth, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier

    .
    Biosynth Bringing End-to-End Offers  to TIDES USA

    Biosynth News Releases

    Find the latest News from Biosynth

    Page 1 of 2
    Biosynth Bringing End-to-End Offers  to TIDES USA
    Biosynth Bringing End-to-End Offers to TIDES USA Learn More >
    Biosynth Showcasing at CPHI North America in Philadelphia
    Biosynth Showcasing at CPHI North America in Philadelphia Learn More >
    Biosynth Exhibiting at Multiple Events in April 2024
    Biosynth Exhibiting at Multiple Events in April 2024 Learn More >
    Biosynth showcasing raw materials portfolio at CACLP China expo
    Biosynth showcasing raw materials portfolio at CACLP China expo Learn More >
    Biosynth blog provides ‘Hormones 101’ briefing
    Biosynth blog provides ‘Hormones 101’ briefing Learn More >
    Biosynth highlights ‘overlooked’ therapeutic exosomes
    Biosynth highlights ‘overlooked’ therapeutic exosomes Learn More >
    Biosynth’s Guide to Peptides, Enzymes and Antibodies’ in Oncology
    Biosynth’s Guide to Peptides, Enzymes and Antibodies’ in Oncology Learn More >
    Leading-edge research and diagnostic tools from Biosynth: helping scientists to combat emerging infectious diseases
    Leading-edge research and diagnostic tools from Biosynth: helping scientists to combat emerging infectious diseases Learn More >
    Biosynth showcasing API capabilities at  CPHI 2023 Barcelona
    Biosynth showcasing API capabilities at CPHI 2023 Barcelona Learn More >
    Biosynth is pleased to announce the acquisition of Pepceuticals, a UK producer of synthetic peptides
    Biosynth is pleased to announce the acquisition of Pepceuticals, a UK producer of synthetic peptides Learn More >
    Biosynth showcasing antibody, epitope mapping and peptide capabilities at Festival of Biologics Basel 2023
    Biosynth showcasing antibody, epitope mapping and peptide capabilities at Festival of Biologics Basel 2023 Learn More >
    Orano Med Teams Up with Biosynth to Develop Their Next Targeting Vector for Radioligand Therapies
    Orano Med Teams Up with Biosynth to Develop Their Next Targeting Vector for Radioligand Therapies Learn More >
    Page 1 of 2